Cambodia Town and the greater Los Angeles area

Mental Health & Dual Diagnosis

How Is Schizophrenia Treated Alongside Addiction?

Medication consistency is the whole game, and housing does more work than most clinical interventions. Both get neglected.

Written by [AUTHOR NAME] · Last updated August 2026 · 6 min read. Prefer to call? Our admissions line is [BRAND PHONE], answered by an admissions clinician.

  • Licensed by the California Department of Health Care Services. License numbers and expiration dates are published on every location page.
  • Accreditation. Status across the network: [ACCREDITATION STATUS].
  • PPO insurance and private pay. We do not accept Medicare, Medicaid, or Medi‑Cal.
  • Named clinical leadership. Our medical director: [MEDICAL DIRECTOR NAME, MD], [MEDICAL DIRECTOR CREDENTIALS].

Quick answer

Medication consistency is the whole game, and housing does more work than most clinical interventions. Both get neglected.

If this is an emergency

Call 911 if someone is unresponsive, having a seizure, breathing slowly or irregularly, or confused with a high fever. For a mental health or suicidal crisis, call or text 988 to reach the Suicide & Crisis Lifeline, available 24 hours a day. This website is not monitored in real time.

Two levers matter more than the rest

Whether the antipsychotic medication is actually taken, and whether somebody has stable housing. Both do more work than any therapy in this combination, and both are routinely neglected in favour of things that are easier to deliver.

Why adherence is the whole game

Substance use reduces the effectiveness of antipsychotic medication and makes consistent use considerably less likely. Less consistent medication means more symptoms, more distress, and more use.

That loop tightens on itself, which is why relapse of psychosis and relapse of substance use so often arrive together. Interrupting it means protecting the medication first.

Long-acting injectable formulations

Worth asking about specifically, because this is where they earn their place. Where remembering a daily tablet is the obstacle — and in this combination it frequently is — a long-acting injectable removes the daily decision entirely.

It is not appropriate for everyone and it is a genuine option that goes unoffered more often than it should. Raise it rather than waiting.

Why housing does clinical work

Stable housing, income and daily structure affect medication consistency, substance use and symptom severity measurably. Homelessness and this combination frequently coincide.

A treatment plan that ignores the practical situation tends to fail regardless of how good the clinical component is. Ask what practical support a service provides or connects to — for this condition it is part of the treatment rather than an extra.

What the plan should contain

  • A psychiatrist on the team rather than available by referral.
  • Antipsychotic medication maintained throughout, reviewed rather than paused.
  • Medication for the substance use disorder where indicated, with interactions accounted for.
  • Practical support — housing, income, benefits, structure.
  • Nicotine addressed rather than ignored, given how common heavy smoking is here.
  • Family or carer involvement where the person wants it.

Cannabis specifically

For somebody with a diagnosis, cannabis use is associated with worse symptoms, more frequent relapse and poorer outcomes. That is a clearer finding than the debate about whether it causes the condition.

It is worth naming as a priority where several substances are involved, alongside alcohol.

The diagnostic caveat

Stimulants and cannabis can produce psychotic symptoms in people without a psychotic illness, and distinguishing substance-induced psychosis from schizophrenia takes time and observation.

A diagnosis made during active use may be revisited. That is not a reason to stop medication in the meantime — it is a reason to give clinicians an accurate substance history so the picture can be read properly.

What to ask a programme

  • Is there a psychiatrist on the team?
  • Will my antipsychotic be continued and reviewed rather than paused?
  • Can you prescribe or arrange a long-acting injectable?
  • What practical support — housing, benefits — do you provide or connect to?

Our page on whether schizophrenia leads to addiction covers the underlying relationship, and our page on how dual diagnosis is treated sets out the wider model.

Frequently asked questions

Should antipsychotic medication continue during addiction treatment?

Yes, and stopping it is a well-recognised route into relapse of psychosis. Substance use already reduces antipsychotic effectiveness and makes consistent use less likely, so a period of treatment is exactly when consistency matters most. If side effects are the problem — and they are a common and legitimate reason people stop — that is a conversation about changing medication rather than a reason to stop taking it. A programme that encourages stopping psychiatric medication because recovery means being free of all substances is applying a position that is not evidence-based.

What is a long-acting injectable and should I ask about it?

It is a formulation of antipsychotic medication given by injection at intervals rather than taken daily, and it is worth asking about specifically because it addresses the main practical obstacle in this combination. Where remembering a daily tablet is the difficulty — and with substance use involved it frequently is — it removes the daily decision entirely. It is not suitable for everyone and it is offered less often than it should be, partly because nobody raises it. Ask whether it is available and whether it would suit your situation rather than waiting to be offered.

Does housing really affect treatment outcomes?

More than most people expect, and for this condition it functions as part of the treatment rather than a social extra. Stable housing, income and daily structure affect medication consistency, substance use and symptom severity in measurable ways, and homelessness frequently coincides with this combination. A clinical plan that ignores the practical situation tends to fail regardless of its quality. Ask what practical support a service provides or connects to — housing, benefits, income — because a programme that treats those as somebody else's problem is unlikely to produce lasting change.

Which substance should be prioritised?

Cannabis and alcohol, generally. For somebody with a schizophrenia diagnosis, cannabis use is associated with worse symptoms, more frequent relapse and poorer outcomes, which is a clearer finding than the debate about causation. Alcohol interferes with medication and disrupts sleep, which destabilises symptoms. Nicotine is extremely common in this group and worth addressing too, given its contribution to the reduced life expectancy associated with the condition, even though it is rarely the immediate priority. This is a conversation for the treating team rather than a decision to make alone.

What if my diagnosis was made while I was using?

It may need revisiting, and that is normal rather than a problem. Stimulants and cannabis can produce psychotic symptoms in people without a psychotic illness, and telling substance-induced psychosis from schizophrenia takes time and observation. A period of stability usually clarifies it. What should not happen is stopping medication in the meantime on the basis that the diagnosis is uncertain. Continue treatment, give clinicians a complete and accurate substance history so they can interpret what they are seeing, and let the picture be reassessed deliberately once things are more settled.

Can family be involved in treatment?

Where you want them to be, yes, and it is worth considering because family involvement has evidence behind it for this condition specifically — around recognising early warning signs, supporting medication consistency and reducing relapse. It requires your consent, and the extent is yours to set. If relationships are difficult or you would rather they were not involved, that is entirely legitimate. Ask what family work a programme offers, since some provide structured family education and support and others do nothing, and the difference matters more here than for most conditions.

What does a good programme look like for this combination?

Ask four things. Is there a psychiatrist on the team rather than available by referral? Will antipsychotic medication be continued and reviewed throughout? Can a long-acting injectable be prescribed or arranged if that would help? And what practical support — housing, benefits, structure — does the service provide or connect to? A programme that answers all four concretely is equipped for this. One that treats the psychiatric side as a referral and the practical side as somebody else's job is not, whatever it says about dual diagnosis.

Sources

  1. National Institute of Mental Health. nimh.nih.gov
  2. National Institute on Drug Abuse. Common Comorbidities with Substance Use Disorders. nida.nih.gov
  3. MedlinePlus, U.S. National Library of Medicine. medlineplus.gov
  4. Substance Abuse and Mental Health Services Administration. samhsa.gov
  5. Substance Abuse and Mental Health Services Administration. National Helpline, 1-800-662-HELP (4357). samhsa.gov

Talk it through with somebody who can answer for your situation.

Verify your insurance
Medical disclaimer This article is for information only and is not a substitute for professional medical advice, diagnosis, or treatment. Substance use disorder is a chronic medical condition; outcomes vary by person, and nothing here promises a particular result. Always talk with a qualified clinician about your situation. Read our editorial and medical disclaimer.